Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeEXECUTIVESFrank OSchell New VP of US Sales at PROTEOR USA

Frank OSchell New VP of US Sales at PROTEOR USA

Frank Oschell has been appointed to Vice President of U.S. Sales, effective immediately. PROTEOR USA annonced the news today.

Frank Oschel joins the PROTEOR USA team, boasting 24 years of experience in the medical field, half of that time spent at Ottobock Healthcare. With expertise in the development and training of consultative, solutions-based sales teams, and in cooperation with value-added marketing and clinically driven education, Frank has gained recognition as a top-performing, results-driven, business leader.

PROTEOR USA President and CEO Matt Swiggum shares: “I am excited to continue building our incredible team at PROTEOR with the addition of Frank Oschell to lead our U.S. Sales and Development activities. He is a seasoned sales professional with strong sales and organizational abilities that I had the pleasure of experiencing first-hand during our time together at Ottobock. As the leader of its fastest-growing business unit, his growth has been founded in his focus on supporting the success of his customers.”

Steve Sherman, previously Vice President of U.S. Sales, passes the torch to Frank Oschell while moving to focus on the development of new global distribution channels while reinforcing current partnerships in an ever-growing international marketplace. Swiggum continues: “With Frank’s focus on the U.S., we are able to focus pivotal resources on international activities. Steve Sherman has accepted the dedicated position as Vice President of International Sales. He has been very instrumental in building the RUSH business and has an entrepreneurial drive that will enable us to continue our rapid growth on a global level.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy